healthcare
White House to Announce New Drug Pricing Deals with Biotechs
The White House is set to finalize pricing agreements with 17 pharmaceutical companies, including Regeneron, as part of an expanded effort to lower U.S. drug costs. These deals, tied to potential tariff relief, aim to align U.S. prices…
By Lila Merrick